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Abstract
Background: Studies comparing perinatal outcomes in multiples conceived following the use of artificial
reproductive technologies (ART) vs. spontaneous conception (SC) have reported conflicting results in terms of
mortality and morbidity. Therefore, the objective of our study was to compare composite outcome of mortality
and severe neonatal morbidities amongst preterm multiple births ≤ 32 weeks gestation infant born following
ART vs. SC.
Methods: We conducted a single center cohort study at Mount Sinai Hospital, Toronto, Ontario, Canada. Data on
all preterm multiple births (≤ 32 weeks GA) discharged between July 2005 and June 2008 were retrospectively
collected from a prospective database at our centre. Details regarding mode of conception were collected
retrospectively from maternal health records. Preterm multiple births were categorized into those born following
ART vs. SC. Composite outcome was defined as combination of death or any of the three neonatal morbidities
(grade 3/4 intraventricular hemorrhage or periventricular leukomalacia; retinopathy of prematurity > stage 2 or
chronic lung disease). Univariate and multivariate regression analysis were preformed after adjustment of
confounders (maternal age, parity, triplets, gestational age, sex, and small for gestational age).
Results: One hundred and thirty seven neonates were born following use of ART and 233 following SC. The
unadjusted composite outcome rate was significantly higher in preterm multiples born following ART vs. SC
[43.1% vs. 26.6%, p = 0.001; OR 1.98 (95% CI 1.13, 3.45)]; however, when adjusted for confounders the difference
between groups was not statistically significant [OR 1.39, 95% CI 0.67, 2.89].
Conclusion: In our population of preterm multiple births, the mode of conception had no detectable effect on
the adjusted composite neonatal outcome of mortality and/or three neonatal morbidities.
Keywords: Assisted reproductive technology, in-vitro fertilization, spontaneous conception, infant-newborn,
mortality, morbidity
Background
Advances in neonatal intensive care have lead to
increased survival of preterm [< 37 weeks’ gestational
age (GA)] infants at extremes of GA with its associated
morbidities [1,2]. Over the last two decades there has
been a steady increase in the incidence of preterm births
worldwide with a range of 7-13% [3,4]. One of the rea-
sons attributed to this increase has been the widespread
use of assisted reproductive techniques (ART) [5,6] lead-
ing to pregnancies with multiple gestations (e.g. twins
and triplets). In Canada in 2009, 29.1% of twin pregnan-
cies and 0.9% of triplets and higher order pregnancies
occurred following the use of ART [6]. Similarly for the
United States, ART accounted for > 1% of all births and
18% of multiple births [7,8]. Studies comparing perinatal
outcomes in multiples conceived following ART vs.
spontaneous conception (SC) have reported conflicting
results in terms of mortality and morbidity [9-11].
Factors that might have contributed to these conflicting
findings include: inclusion of term and preterm infants
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any medium, provided the original work is properly cited.in the cohort, studies with small sample size and failure
to control for perinatal characteristics [12,13].
To date, there have been two published reports com-
paring outcomes of very low birth weight (VLBW)
infants (≤ 1500 grams) conceived following ART vs. SC.
Schimmel et al [14] reported that the risk of congenital
malformations, mortality and neonatal morbidities
[respiratory distress syndrome (RDS), patent ductus
arteriosus (PDA), necrotizing enterocolitis (NEC), intra-
ventricular hemorrhage (grades III/IV) and bronchopul-
monary dysplasia (BPD)] were not increased in infants
conceived by in vitro fertilization (IVF). Similarly, Mes-
serschmidt et al [15] reported no difference in mortality,
short-term pulmonary morbidity defined as the presence
or absence of respiratory distress requiring the use of
mechanical ventilation and surfactant administration
and cerebral morbidity [grades 3/4 IVH or cystic peri-
ventricular leucomalacia (PVL)] among VLBW infants
after IVF conception. There were no differences identi-
fied even when the group was divided in BW < 1000 g
and 1000-1499 g. In both of these studies, outcomes
were compared amongst singletons and multiples (twins
and triplets) following ART vs. SC conception. However,
increased neonatal morbidity has been attributed to
plurality [6] and hence in our study we focused on mor-
tality and severe neonatal morbidities amongst multiple
births ≤ 32 weeks gestation infants born following ART
vs. SC.
The objective of this study was to compare the com-
posite outcome (death or severe neonatal morbidities)
among multiple births ≤ 32 weeks GA born following
ART vs. SC. We hypothesizedt h a tp r e t e r mm u l t i p l e
births ≤ 32 weeks GA born following the use of ART
will have increased rate of adverse composite outcome.
For the purpose of this study ART was defined as the
use of artificial (infertility treatments in which both the
oocytes and sperms are manipulated) or partially artifi-
cial (intracytoplasmic sperm injection and intrauterine
insemination) methods to achieve pregnancy.
Methods
We conducted a single center cohort study at Mount Sinai
Hospital, Toronto, Ontario, Canada. Mount Sinai Hospital
is a high-risk perinatal center and infants included in the
study were inborn. Once the infants are stable (i.e. off ven-
tilatory support) they may be transferred to the commu-
nity hospital closer to home. Data were retrospectively
collected from a prospective database for all preterm mul-
tiple births discharged between July 2005 and June 2008.
Data on all NICU admissions were collected daily by
either staff neonatologist or trained data abstractor
according to predefined definitions and guidelines. Infor-
mation on daily progress and clinical status, need for
intensive care, resource utilization, cranial ultrasound scan
and eye examination were collected. Data regarding
maternal demographics, type of ART, use of antenatal
steroids, maternal hypertension and diabetes during preg-
nancy and mode of delivery were collected from maternal
health records.
Study population
Preterm multiple births born at ≤ 32 weeks GA were
included in this study. Neonates were divided into two
groups: those conceived following the use of ART and
those conceived spontaneously. Assisted reproductive
technology was defined as the use of artificial (infertility
treatments in which both the oocytes and sperms are
manipulated) or partially artificial (intracytoplasmic
sperm injection and intrauterine insemination) methods
to achieve pregnancy. Infants with major congenital
anomalies were excluded as it could influence our pri-
mary outcome [16]. The local research ethics board at
our institution approved the database and this study.
Outcomes
T h ep r i m a r yo u t c o m eo fo u rs t u d yw a st h ec o m p o s i t e
outcome of mortality or any of the three neonatal mor-
bidities [grade 3/4 IVH, or PVL, retinopathy of prema-
turity (ROP) > stage 2 or chronic lung disease (CLD)].
Secondary outcomes included individual components of
the primary outcome, duration of positive pressure ven-
tilation, duration of hospital stay, incidence of PDA, sep-
sis and NEC. Gestational age was defined as the best
obstetric estimate based on early prenatal ultrasound,
obstetric examination, and obstetric history. An infant
was defined as small-for-gestational age (SGA) if the
birth weight was less than the 3
rd percentile for GA
according to the published data for Canadian infants
[17]. Transport risk index of physiologic stability
(TRIPS) scores were calculated from variables during
the first 12 hours of admission to the NICU [18]. Mor-
tality was defined as death occurring before discharge
from the NICU. Information on death is not ascertained
once the infant is transferred or discharged from our
unit due to confidentiality issues. Further, the timing of
death in both groups was delineated. Chronic lung dis-
ease was defined as oxygen dependency at 36 weeks cor-
rected GA (CGA). Infants who were discharged from
the NICU on oxygen before they reached 36 weeks
CGA were classified as having CLD. Infants who died
before they reached 36 weeks CGA were excluded from
the analysis for CLD. Intraventricular hemorrhage was
diagnosed according to the criteria of Papile from the
worst findings on head ultrasound for all infants who
underwent a head ultrasound after 24 hours of life [19].
Necrotizing enterocolitis was defined according to Bell’s
criteria (stage 2 or higher) [20]. Sepsis was defined as
isolation of organisms from a normally sterile site
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arteriosus was diagnosed clinically based on symptoms
and signs. The outcomes of NEC, sepsis and PDA were
ascertained at any time during their hospital stay. Reti-
nopathy of prematurity (ROP) was classified according
to international classification [21]. Infants were eligible
to undergo screening for ROP if they were born at ≤ 30
weeks GA or with birth weight ≤ 1,500 grams. They
would be screened starting from 4-6 weeks postnatal
age as per the Canadian Paediatric Society recommenda-
tions [22,23].
Statistical analysis
Demographic characteristics and neonatal outcomes
between groups were compared using c
2 or Fisher’s
exact test for categorical data and Student’st - t e s to r
Mann-Whitney test for continuous data as appropriate.
Odds ratio (OR) and 95% confidence interval (CI) was
reported as appropriate. Logistic regression analysis was
used to assess the independent effect of ART on compo-
site outcome (death and/or any of the three neonatal
morbidities) after adjusting for the following confound-
ing variables: maternal age, parity, multiple type (tri-
plets), GA, sex and SGA status. These variables were
selected as they were noted to be statistically signifi-
cantly different between groups on univariate analysis.
However, as deaths in the delivery room were included
in our analysis, infants who died in the delivery room
were most likely to have low Apgar score at 5 minutes.
Therefore, it may be an intervening variable in the
model. Hence, logistic regression analysis was performed
by including and excluding Apgar score at 5 minutes in
t h em o d e l .A st h e r ew a sn od i f f e r e n c ei nt h er e s u l t si n
the two models, we present the results from the model
that excluded Apgar score at 5 minutes. Generalized
estimating equations (GEE) were used to control for
correlation between multiples born to the same
mothers. Statistical analysis was performed using SAS
version 9.2 (SAS institute, Cary, NC). A p-value of <
0.05 was considered significant.
Results
A total of 3208 infants were admitted to our NICU dur-
ing the study period. Eleven hundred and thirty infants
were ≤ 32 weeks gestation at the time of birth of which
370 were preterm multiples. One hundred and thirty-
seven infants (from 65 mothers) were born following
conception through ART and 233 (from 128 mothers)
were born following SC. Baseline maternal and neonatal
characteristics are presented in Tables 1 and 2 respec-
tively. Maternal age was significantly higher [33.5 (5.3)
vs. 29.5 (5.8) years; p < 0.01], mothers were more likely
to be primiparous, and the rate of triplets was higher in
t h eA R Tg r o u p( p<0 . 0 1 ) .T h em e a nG Aa n db i r t h
weight were significantly lower in multiples born follow-
ing ART vs. SC [28 (2.6) vs. 29 (2.2) weeks; p < 0.01]
and [1099 (391) vs. 1213 (375) grams; p < 0.01] respec-
tively. The distributions of the Apgar scores at 5 min-
utes were significantly different between ART vs. SC
Table 1 Baseline maternal characteristics
Variable* Assisted reproductive
technology (ART)
group (N = 65)
Spontaneous
conception (SC)
group (N = 128)
p value
Maternal age
(years)
33.4 (5.4) 29.3 (5.7) < 0.01
Gravida
[median
(range)]
1 (1, 9) 2 (1, 8) 0.01
Parity
[median
(range)]
0 (0, 3) 0 (0, 6) < 0.01
Gestational
diabetes [N
(%)]
6 (9.2%) 6 (4.7%) 0.22
Hypertension
[N (%)]
8 (12.3%) 15 (11.7%) 0.90
Use of
antenatal
steroid [N
(%)]
59 (92.2%) 111 (87.4%) 0.31
Multiple type
Twins 46 (70.8%) 119 (93%) < 0.001
Triplets 18 (28.1%) 9 (7%)
Quadruplets 1 (1.5%) 0
*Results are presented as mean (SD) or median (range) or number [N (%)] as
appropriate.
Table 2 Baseline neonatal characteristics
Variable* Preterm multiple
births following
ART (N = 137)
Preterm multiple
births following
SC (N = 233)
p value
Gestational
age (weeks)
28 (2.6) 29 (2.2) < 0.01
Birth weight
(grams)
1099 (391) 1213 (375) < 0.01
Male [N (%)] 76 (55.5%) 148 (63.5%) 0.12
Small for
gestational
age [N (%)]
8 (5.8%) 25 (10.7%) 0.11
Caesarean
section (%)
81 (59.1%) 138 (59.2%) 0.98
Apgar score
(1 minute)
5 (0, 9) 7 (0, 9) < 0.01
Apgar score
(5 minutes)
8 (1, 10) 8 (1, 10) < 0.01
TRIPS at birth 14 (0, 55) 12 (0, 65) 0.01
TRIPS at 12
hours of age
14 (0, 31) 14 (0, 44) 0.28
*Results are presented as mean (SD) or median (range) or number [N (%)] as
appropriate.
TRIPS, transport risk index of physiologic stability.
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IVF (81%), intracytoplasmic sperm injection (4%) and
intrauterine insemination (15%).
The composite outcome rate was significantly higher
in the ART group [(43.1% vs. 26.6%, p < 0.01; unad-
justed OR 1.98, 95% CI 1.13, 3.45]. When adjusted for
confounding factors there was no significant difference
in the composite outcome rate between the 2 groups
[OR 1.39, 95% CI 0.67, 2.89]. Significant predictors for
the composite outcome were: GA (p < 0.01) and being
SGA (p < 0.03). Maternal age, parity, multiple type (tri-
plets) and sex did not influence the composite outcome.
Mortality and incidence of CLD were significantly
higher in the ART group (p < 0.05). The incidences of
PDA, NEC, sepsis, IVH and ROP were similar in both
groups (Table 3). There were no differences in the
duration of ventilation and length of hospital stay
between the 2 groups (p > 0. 05).
Discussion
In our study, the mode of conception did not influence
neonatal mortality and morbidities in preterm multiples
born at ≤ 32 weeks GA. Our findings are consistent
with the studies published by Schimmel et a [14] and
M e s s e rS c h m i d te ta l[ 1 5 ]w h oc o m p a r e do u t c o m e so f
singleton and multiples VLBW infants conceived by IVF
compared to SC. After accounting for confounding vari-
ables (maternal age, parity, multiple type, GA, sex, and
SGA) there was no difference in the incidence of neona-
tal morbidity or mortality among IVF-conceived infants.
Regression analysis in our study revealed that GA and
being SGA contributed to the adverse neonatal out-
come. Further, infants in the ART group had higher
mortality and incidence of CLD which can be explained
by a one week difference in the GA between the two
groups.
Maternal characteristics were different between the
two groups for age, parity and type of multiples.
Women in the ART group were more likely to be older
and primiparous at the time of conception. This finding
is consistent with other published studies in the litera-
ture [11,14,24,25]. There was no statistically significant
increase in the use of antenatal steroids in women who
conceived after ART vs. SC. In a case-control study on
twins, Nassar et al [26] reported higher use of antenatal
steroid in the IVF group compared to SC group, how-
ever that did not achieve statistical significance. Our
rates of Caesarean section were not different between
groups which are in contrast to what is reported in the
published literature [12,26]. Variation in obstetrical
practices amongst centers may account for the differ-
ences observed in our study. It is likely that women who
conceive through ART receive close follow-up and are
managed more aggressively [11].
Since the birth of the first IVF conceived infant in
1978, diverse ART techniques have developed rapidly
and implemented in clinical practice. However, despite
its adoption in practice no systematic effort has been
made to scrutinize the safety of such treatments in rela-
tion to perinatal outcomes. To date, however, several
systematic reviews and meta-analysis have been pub-
lished on this topic [27-29]. The risk of preterm birth,
LBW and VLBW were significantly increased in single-
ton pregnancies conceived by ART [27,28]. However,
these findings should be interpreted with caution. Lim-
itations of the published studies include: a) clinicians
were not blinded to the mode of conception resulting in
differential management of ART pregnancy with a low
threshold to intervene if obstetrical complications arose;
b) the pregnancy may have begun as a multi-fetal
Table 3 Neonatal outcomes
Variables* Preterm multiples
born following
ART (N = 137)
Multiples
born
following SC
(N = 233)
p value
Composite outcome†
Death or any of the
three severe neonatal
morbidities [N (%)]
59/137 (43.1%) 62/233 (26.6%) < 0.01
Individual outcomes on mortality and neonatal morbidities
Mortality [N (%)] 28/137 (20.4%) 27/233 (11.6%) 0.02
Timing of infant death
Within 1 day 12 (42.9%) 7 (25.9%) 0.49
2 - 6 days 6 (21.4%) 10 (37.0%)
7 - 27 days 9 (32.1%) 8 (29.6%)
≥ 28 days 1 (3.6%) 2 (7.4%)
CLD
a [N (%)] 32/110 (29.1%) 31/206 (15.1%) 0.01
ROP > stage 2
b [N (%)] 9/90 (10.0%) 8/155 (5.2%) 0.15
Grade 3/4 IVH/PVL
c [N
(%)]
12/125 (9.6%) 14/226 (6.2%) 0.24
PDA [N (%)] 35/137 (25.6%) 41/233 (17.6%) 0.06
NEC [N (%)] 7/137 (5.1%) 9/233 (4%) 0.58
Sepsis [N (%)] 25/137 (18.3%) 36/233 (15.5%) 0.48
Duration of positive
pressure ventilation
(days)
6 (0, 101) 9 (0, 149) 0.08
Length of stay (days) 24 (1, 144) 25 (1, 165) 0.10
*Results are presented as number [N (%)] or median (range) as appropriate.
†Composite outcome includes mortality or any of the three neonatal
morbidities (grade 3/4 IVH or PVL, retinopathy of prematurity (ROP) > stage 2
or CLD).
Denominator for each variable is as follows.
aInfants on whom the outcome were ascertained (explanation in the methods
section).
bInfants who were eligible for screening.
cInfants who are alive for more than 24 hours.
CLD, chronic lung disease; ROP, retinopathy of prematurity; PVL,
periventricular leucomalacia, PDA, patent ductus arteriosus; NEC, necrotizing
enterocolitis.
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associated with adverse perinatal outcomes and c) not
all studies accounted for confounders. Similarly, McDo-
nald et al [29] reported an increased risk of preterm
birth for twin pregnancies in the IVF group. However,
this finding was not replicated in a population based
study when adjusted for socioeconomic status [11]. The
comparable outcome may be attributed to enhanced
monitoring and perinatal care in ART pregnancies.
The precise mechanism by which ART may increase
the risk of preterm birth is not clear. Suggested mechan-
isms include: the infertility treatment, the cause of infer-
tility (reproductive pathology in the couple themselves)
or may be related to physician or patient anxiety (iatro-
genic early delivery). Increased levels of relaxin, a
powerful stimulator of collagen breakdown has been
observed in gonadotropin stimulated pregnancies which
persists throughout the pregnancy. It has been identified
as an independent risk factor for preterm birth as it
leads to premature cervical changes and delivery [30].
There are several limitations to our study. It is possi-
ble that women in the SC group may have received
treatment such as the use of ovulation inducing agents
which could influence our results towards the null
hypothesis (i.e. no difference in the outcome). We were
unable to evaluate the influence of chorionicity on out-
c o m e sb e t w e e nt h eg r o u p sa st h i si n f o r m a t i o nw a sn o t
consistently recorded in the maternal charts. In this
study we excluded singletons; therefore we are unable to
comment on the influence of plurality on the composite
outcome. Further, the limited sample size in our study
may account for our inability to demonstrate a differ-
ence in the short-term outcomes between the two
groups. Lastly, the long-term neuro-developmental out-
come data were not available for our cohort even
though majority of studies have not shown an increased
rate of adverse major neuro-developmental outcomes
such as cerebral palsy, cognitive and language deficits
and behavioral problems in ch i l d r e nb o r nf o l l o w i n gt h e
use of IVF or intracytoplasmic sperm injection. Minor
deficits cannot be ruled out as in most studies the eva-
luation was performed during infancy [31].
Despite these limitations, we believe that the informa-
tion from this study has clinical implications. Providing
appropriate counseling that adverse outcomes is related
to the GA at birth rather than ART itself may be reas-
s u r i n gt ot h ec o u p l ew h oa r ea l r e a d yl i v i n gw i t ht h e
financial and psychological stress of using ART for con-
ception. Multi-fetal pregnancies in general are associated
with adverse perinatal outcomes whether conceived by
ART or SC. In order to reduce the risk of multi-fetal
pregnancies, it is vital to counsel couples regarding the
obstetrical, perinatal neonatal risk of such a pregnancy
so that they can make an informed decision regarding
number of embryos that should be transferred per cycle.
The success of ART intervention should be quantified
in terms of maternal and neonatal outcomes rather than
the number of embryos who survived the procedure.
Conclusion
In our population of multiples ≤ 32 weeks GA, the
mode of conception did not influence the rate of mor-
tality or short-term neonatal morbidities. Further,
research on long-term neuro-developmental outcomes
of these infants is needed.
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